Glycosan Biosystems Patents

Patent portfolio assigned to Glycosan Biosystems (verified via public assignee records). Salt Lake City UT biotech; HyStem/Extracel hyaluronan-based hydrogels for cell culture and therapy; licensed University of Utah IP (Prestwich/Shu). Acquired by BioTime in 2011. Patents EP2523656A1, WO2011161174A1, US7651702 found. Sells generically to researchers; no named customers; no direct competitors confirmed via fetched sources.